Skip to main content
. 2020 Mar 12;3:35. doi: 10.1038/s41746-020-0243-5

Table 1.

Baseline characteristics of the trial participants.

Total
(N = 572)
CASC
(N = 285)
Control
(N = 287)
Age 46 ± 11 47 ± 11 45 ± 12
Age ranges
 <40 years 171 (30) 75 (26) 96 (33)
 40–49 years 179 (31) 97 (34) 82 (29)
 50–59 years 159 (28) 82 (29) 77 (27)
 ≥60 years 63 (11) 31 (11) 32 (11)
Male sex 426 (75) 216 (76) 210 (73)
Smoking history
 Years of smoking 25 (18–33) 25 (19–32) 24 (17–33)
 Cigarettes per day 20 (15–20) 20 (15–20) 20 (15–20)
 Pack-years 20 (14–30) 21 (14–30) 20 (13–31)
 Exhaled CO (ppm) 17 ± 11 17 ± 10 18 ± 11
 TDS score 7.7 ± 1.5 7.7 ± 1.4 7.8 ± 1.5
 FTND 5.3 ± 2.1 5.2 ± 2.0 5.3 ± 2.1
Comorbidities
 Cardiovascular diseases 93 (16) 45 (16) 48 (17)
 Respiratory diseases 93 (16) 48 (17) 45 (16)
 Psychiatric diseases 31 (5) 12 (4) 19 (7)
Prescribed Medication
 Varenicline 454 (79) 227 (80) 227 (79)
 Nicotine patch 114 (20) 56 (20) 58 (20)
 No medication 4 (1) 2 (1) 2 (1)

Data include mean ± standard deviation, number (%), or median (interquartile range) scores.

CO carbon monoxide, FTND Fagerström test for nicotine dependence, and TDS tobacco dependence screener.